首页 | 本学科首页   官方微博 | 高级检索  
检索        

康莱特注射液联合TP化疗方案治疗局部晚期非小细胞肺癌的临床观察
引用本文:郑中显,潘明.康莱特注射液联合TP化疗方案治疗局部晚期非小细胞肺癌的临床观察[J].安徽医药,2009,13(1):67-68.
作者姓名:郑中显  潘明
作者单位:安徽省池州市人民医院肿瘤科,安徽,池州,247000;安徽省池州市人民医院肿瘤科,安徽,池州,247000
摘    要:目的探讨康莱特注射液联合TP化疗方案治疗局部晚期非小细胞肺癌的临床疗效。方法将30例非小细胞肺癌(NSCLC)患者分入康莱特注射液加TP方案化疗组(试验组)和单纯TP方案化疗组(对照组)。试验组有效率(CR+PR)为40%(6/15),对照组有效率为33.3%(5/15),略有提高,但差异无统计学意义,P〉0.05;而临床获益率CR+PR+SD却明显提高,P=0.0412。结果化疗的毒副反应恶心、呕吐、白细胞减少、血小板减少及贫血等发生率均明显低于对照组。结论康莱特联合化疗对于NSCLC患者具有增效减毒的功效,可提高患者的生存质量。

关 键 词:非小细胞肺癌  抗肿瘤药  康莱特(薏苡仁)注射液

Clinical study of combined Kanglaite injection with chemotherapy(TP scheme) in treatment of NSCLC
ZHENG Zhong-xian,PAN Ming.Clinical study of combined Kanglaite injection with chemotherapy(TP scheme) in treatment of NSCLC[J].Anhui Medical and Pharmaceutical Journal,2009,13(1):67-68.
Authors:ZHENG Zhong-xian  PAN Ming
Institution:ZHENG Zhong-xian,PAN Ming(Department of Medical Oncology,Chizhou People\'s Hospital,Chizhon 247000)
Abstract:Aim To explore clinical study of combined Kanglaite injection with chemotherapy(TP scheme) in treatment of NSCLC.Methods Thirty patients with non-small cell lung cancer(NSCLC) were involued in a randomized and controlled study.The patients were divided into trial group in which patients received combined chemotherapy(TP scheme) plus Kanglaite(KLT) injection,and control group in which patients received simple combined chemotherapy(TP scheme).The efficacy rates(CR+PR)were 40% in the trial group,and 33.3% in t...
Keywords:non-small cell lung  antitumor drug  Kanglaite injection  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号